Gaskin K J, Durie P R, Hill R E, Lee L M, Forstner G G
J Clin Invest. 1982 Feb;69(2):427-34. doi: 10.1172/jci110466.
Human pancreatic lipase in duodenal secretions was studied under conditions of maximal activation by porcine colipase and maximal inhibition by sodium taurodeoxycholate. In almost all samples, total lipase activity in 4 mM sodium taurodeoxycholate was activated by the addition of porcine colipase. Activation was linear until saturation by cofactor was reached, and maximum activity was greater than that obtained in the absence of bile salts. At pH 8.0 in 4 mM sodium taurodeoxycholate, lipase activity was due to pancreatic lipase in samples from normal and steatorrheic individuals and was proportional to the concentration of endogenous colipase in samples that could be activated by exogenous colipase. In these samples, therefore, colipase activity could be conveniently assayed as the lipase activity at pH 0.8 in 4 mM sodium taurodeoxycholate. Colipase to total pancreatic lipase ratios varied widely from individual to individual and on average were significantly lower in steatorrheic patients. In individual samples, colipase secretion was stimulated by pancreozymin and secretin roughly in parallel with total pancreatic lipase, but some variation in the ratio of the two was often seen in successive collection periods. Because pancreatic lipase is usually unsaturated with respect to cofactor, lipolytic activity in duodenal secretions may be finely controlled by modulation of colipase secretion.
在猪胰辅脂酶最大激活和牛磺脱氧胆酸钠最大抑制的条件下,对十二指肠分泌物中的人胰脂肪酶进行了研究。在几乎所有样本中,4 mM牛磺脱氧胆酸钠中的总脂肪酶活性通过添加猪胰辅脂酶而被激活。在达到辅因子饱和之前,激活呈线性,最大活性高于无胆盐时获得的活性。在4 mM牛磺脱氧胆酸钠中,pH 8.0时,正常人和脂肪泻患者样本中的脂肪酶活性归因于胰脂肪酶,且与可被外源性胰辅脂酶激活的样本中内源性胰辅脂酶的浓度成正比。因此,在这些样本中,胰辅脂酶活性可以方便地通过在4 mM牛磺脱氧胆酸钠中pH 8.0时的脂肪酶活性来测定。胰辅脂酶与总胰脂肪酶的比例在个体之间差异很大,脂肪泻患者的平均比例明显较低。在个体样本中,胰酶泌素和促胰液素刺激胰辅脂酶分泌,大致与总胰脂肪酶平行,但在连续采集期间,两者比例经常会有一些变化。由于胰脂肪酶通常相对于辅因子不饱和,十二指肠分泌物中的脂解活性可能通过调节胰辅脂酶分泌而得到精细控制。